Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
863.45
-7.75
(-0.89%)
< Home
< Back
Zydus Lifesciences Ltd. News
>>
Cadila Healthcare submits disclosure
>>
Cadila Healthcare submits disclosure
>>
Zydus Group aims two more novel drugs by 2020
>>
Cadila Healthcare submits disclosure
>>
Zydus Group pioneers breakthrough with anti-diabetic drug Lipaglyn
>>
Cadila Healthcare reports 54% rise in Q4 consolidated net profit
>>
Cadila Healthcare gains on launching Zolmitriptan in US market
>>
Cadila Healthcare launches Zolmitriptan in US market
>>
Cadila Healthcare loses Prevacid SoluTab patent infringement case v/s Takeda: Report
>>
Cadila gains on approving merger of its 3 subsidiaries with itself
<<
<
162
163
164
...168
>
>>